Century Therapeutics Completes $160 Million Series C Financing to Accelerate Development of iPSC-derived Cell Therapy Pipeline

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/309UqAz
via IFTTT